Creative Planning’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.9K Buy
211,955
+86,328
+69% +$24.1K ﹤0.01% 4156
2026
Q1
$41.3K Buy
125,627
+80,016
+175% +$126K ﹤0.01% 3999
2025
Q4
$141K Buy
45,611
+26,956
+144% +$76.9K ﹤0.01% 3645
2025
Q3
$49.1K Buy
+18,655
New +$41.1K ﹤0.01% 3757
2020
Q4
Sell
-13,222
Closed -$164K 2395
2020
Q3
$164K Buy
+13,222
New +$175K ﹤0.01% 1727
2020
Q2
Sell
-12,000
Closed -$122K 2061
2020
Q1
$122K Hold
12,000
﹤0.01% 1491
2019
Q4
$188K Hold
12,000
﹤0.01% 1653
2019
Q3
$201K Hold
12,000
﹤0.01% 1606
2019
Q2
$266K Hold
12,000
﹤0.01% 1444
2019
Q1
$260K Buy
+12,000
New +$250K ﹤0.01% 1416

Other funds holding GOSS

Creative Planning's GOSS Position: Q2 2026 in Review

Creative Planning increased its Gossamer Bio (GOSS) stake by 69% in Q2 2026, buying an estimated $24.1K and bringing the position to 211,955 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4156.

Creative Planning first reported a position in GOSS in Q1 2019 and has held it in 10 quarters since. The position peaked at $266K in Q2 2019. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Creative Planning held 211,955 shares of Gossamer Bio worth $34.9K as of Q2 2026.
  • Creative Planning bought 86,328 Gossamer Bio shares in Q2 2026, an estimated $24.1K.
  • Gossamer Bio made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4156 holding.
  • Creative Planning first reported a position in Gossamer Bio in Q1 2019 and has held it in 10 quarters since.
  • Creative Planning's Gossamer Bio position peaked at $266K in Q2 2019.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.